Home Search

viaskin peanut - search results

If you're not happy with the results, please do another search
Viaskin Patch

Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in Children

0
95.5% of the participants completed treatment, with most adverse effects being mild or moderate reactions at the application site.
Viaskin-Patch

FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial to Commence

0
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Viaskin Patch

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy

0
According to research presented at this year's #ACAAI22 meeting.
DBV Patch Closeup

DBV, Developers of Patch Therapies for Allergies to Peanuts, Milk and Eggs, to Lay...

0
The company announced they would be laying off 200 employees in Q1.
FARE Reponse to ICER Report

Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies

FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.
AAFA Reponse to ICER Report

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut...

0
The AAFA addresses concerns regarding the Final Evidence Report released by the ICER.
ICER Final Report

ICER’s Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That...

The report evaluates Viaskin® Peanut and AR101, as well as non-commercialized oral immunotherapy (OIT).
AAFA Press Release Regarding ICER Review

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER Review of New...

Affirms Burden of Food Allergies on Families, Patients, and Caregivers.
FARE-ACAAI-AAN Statement

Joint Statement on Peanut Allergy Therapy Review

Organizations representing patients and allergists urge ICER to adopt a more patient-driven approach to assessing immunotherapies for peanut allergy.
Peanuts

Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for Peanut Allergy

0
An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.